This theory is further supported by studies showing that Atr loss is synthetic lethal with disruption of other tumor suppressor genes like Tp53 [82] or oncogene-driven replication damage [47–50] and ongoing clinical trials on ATR inhibitors. Here, TP53 is linked to neoplasm.